Q: What was the study design?

Single-centre retrospective cohort, Level 3 evidence, n=365 (subgroup analyses on 50 and 315 patients, and down to 71 non-sport-injury patients). Population is a mixed ACL reconstruction cohort from one US academic practice, not sport- or age-restricted.

Q: How trustworthy is the methodology?

MH diagnoses were ascertained from medication lists, ICD-10 codes and chart notes rather than a validated screening instrument, which almost certainly undercounts true MH burden and introduces detection bias dependent on documentation habits. This is retrospective chart-based cohort work with no randomisation or blinding (none needed for this design, but confounding by indication is unaddressed): non-sport-related injuries could differ systematically in mechanism, concomitant trauma, compensation/litigation context or baseline psychosocial stress, any of which could independently drive both worse baseline scores and new MH diagnoses. The headline comparisons rest on very small numerators (8 total new MH diagnoses, 50 pre-existing-MH patients), so confidence intervals around these percentages are wide even though a p-value is reported.

Q: What is the overall appraisal?

The PROMIS Mental Health result (47.3 vs 53.6) is close to a tautology since it is comparing people with and without a documented MH diagnosis on a mental health scale; it tells you the diagnosis groups were correctly identified, not much else. The KOOS and new-diagnosis findings are statistically significant but built on tiny absolute numbers (a handful of patients driving the 7% vs 1.6% comparison), and the only sustained patient-reported outcome difference by MH status actually washed out by the first follow-up beyond 2 weeks, so the clinically meaningful signal is thin. This design can show association, not causation, between injury mechanism and new psychiatric diagnosis.

Q: What is the main limitation?

With only 8 new MH diagnoses in the whole non-pre-existing-MH cohort, the non-sport vs sport comparison is underpowered and vulnerable to confounding by what actually caused the non-sport injury; a prospective study using validated screening tools (PHQ-9, GAD-7) rather than chart/ICD capture is needed before trusting the magnitude of this effect.

Q: What should clinicians do on Monday?

Don't change management from this alone. Two low-cost things are reasonable now: tell patients with a pre-existing anxiety/depression diagnosis to expect a rougher first fortnight on knee-specific scores, not a worse 12-month outcome, since that's where the group difference actually lived; that reassurance is itself a useful intervention. And for patients whose ACL tear was non-sport-related (fall, RTA, workplace injury), build in a brief mental health check-in during the first post-op year, since the absolute risk of a new diagnosis in that group, while still low and resting on small numbers, was roughly four-fold higher than after sporting injuries.

Q: How do I apply this in practice?

In clinic: a documented anxiety/depression history is a signal to set expectations at 2 weeks (lower knee scores, more complaints), not a flag for a worse 12-month trajectory, use it to manage the early conversation rather than to predict a poor outcome. For non-sport-related tears specifically, fold a one-line mental health check ('how are you coping with all this?') into the first post-op month and have a GP/psychology referral ready, since this is the group carrying almost all the new-diagnosis signal, small as it is. On the S&C floor, treat injury mechanism as part of the return-to-sport picture: an athlete coming back from a fall or non-sport trauma warrants the same conversation alongside objective RTS testing (hop tests, ACL-RSI-type readiness tools), not gatekeeping return-to-train on knee metrics alone when the athlete's mechanism or demeanour suggests they're struggling psychologically. None of this changes dosage, criteria, or thresholds, it's a prompt to ask and refer, not a new test.

Question 1

What did the study find?

Accepted Answer

The 50 patients (13.7%) with a pre-existing mental health diagnosis had lower baseline PROMIS Mental Health scores (47.3 vs 53.6, P<0.001, which is almost tautological) and worse KOOS at 2 weeks postop, but no difference at any later timepoint. Among 315 patients with no prior MH history, only 8 (2.5%) developed a new MH diagnosis by 1 year, and this was more common after non-sport-related injuries (7% vs 1.6%, P=0.02).

Question 2

What was the study design?

Accepted Answer

Single-centre retrospective cohort, Level 3 evidence, n=365 (subgroup analyses on 50 and 315 patients, and down to 71 non-sport-injury patients). Population is a mixed ACL reconstruction cohort from one US academic practice, not sport- or age-restricted.

Question 3

How trustworthy is the methodology?

Accepted Answer

MH diagnoses were ascertained from medication lists, ICD-10 codes and chart notes rather than a validated screening instrument, which almost certainly undercounts true MH burden and introduces detection bias dependent on documentation habits. This is retrospective chart-based cohort work with no randomisation or blinding (none needed for this design, but confounding by indication is unaddressed): non-sport-related injuries could differ systematically in mechanism, concomitant trauma, compensation/litigation context or baseline psychosocial stress, any of which could independently drive both worse baseline scores and new MH diagnoses. The headline comparisons rest on very small numerators (8 total new MH diagnoses, 50 pre-existing-MH patients), so confidence intervals around these percentages are wide even though a p-value is reported.

Question 4

What is the overall appraisal?

Accepted Answer

The PROMIS Mental Health result (47.3 vs 53.6) is close to a tautology since it is comparing people with and without a documented MH diagnosis on a mental health scale; it tells you the diagnosis groups were correctly identified, not much else. The KOOS and new-diagnosis findings are statistically significant but built on tiny absolute numbers (a handful of patients driving the 7% vs 1.6% comparison), and the only sustained patient-reported outcome difference by MH status actually washed out by the first follow-up beyond 2 weeks, so the clinically meaningful signal is thin. This design can show association, not causation, between injury mechanism and new psychiatric diagnosis.

Question 5

What is the main limitation?

Accepted Answer

With only 8 new MH diagnoses in the whole non-pre-existing-MH cohort, the non-sport vs sport comparison is underpowered and vulnerable to confounding by what actually caused the non-sport injury; a prospective study using validated screening tools (PHQ-9, GAD-7) rather than chart/ICD capture is needed before trusting the magnitude of this effect.

Question 6

What should clinicians do on Monday?

Accepted Answer

Don't change management from this alone. Two low-cost things are reasonable now: tell patients with a pre-existing anxiety/depression diagnosis to expect a rougher first fortnight on knee-specific scores, not a worse 12-month outcome, since that's where the group difference actually lived; that reassurance is itself a useful intervention. And for patients whose ACL tear was non-sport-related (fall, RTA, workplace injury), build in a brief mental health check-in during the first post-op year, since the absolute risk of a new diagnosis in that group, while still low and resting on small numbers, was roughly four-fold higher than after sporting injuries.

Question 7

How do I apply this in practice?

Accepted Answer

In clinic: a documented anxiety/depression history is a signal to set expectations at 2 weeks (lower knee scores, more complaints), not a flag for a worse 12-month trajectory, use it to manage the early conversation rather than to predict a poor outcome. For non-sport-related tears specifically, fold a one-line mental health check ('how are you coping with all this?') into the first post-op month and have a GP/psychology referral ready, since this is the group carrying almost all the new-diagnosis signal, small as it is. On the S&C floor, treat injury mechanism as part of the return-to-sport picture: an athlete coming back from a fall or non-sport trauma warrants the same conversation alongside objective RTS testing (hop tests, ACL-RSI-type readiness tools), not gatekeeping return-to-train on knee metrics alone when the athlete's mechanism or demeanour suggests they're struggling psychologically. None of this changes dosage, criteria, or thresholds, it's a prompt to ask and refer, not a new test.

Anterior Cruciate Ligament Reconstruction and Mental Health: A Bidirectional Relationship

The paper

What they found

Study design

Methodology

The appraisal

The gap

Landmark context

What to do Monday

In practice

The five papers that matter — every week, free.

Related appraisals